Japanese visitors see German medical biotechnology at work first-hand
Japanese medical biotechnology industry experts got a good look at what German medical biotech has to offer early in November. The export initiative for the German Healthcare Industry, HEALTH MADE IN GERMANY and Germany Trade & Invest (GTAI), invited a Japanese delegation to tour some of the country's biotechnology locations in the run up to BIO-Europe, the continent's most important biotech trade fair.
The "Pre BIO-Europe Tour" included expert briefings, official dialogues with political participation, and visits to diverse biotechnology clusters, research institutions, and local companies, as well as a range of networking events. The visitors were given ample opportunities to examine the sector first-hand. The tour's emphasis was the biotechnology location of Eastern Germany.
Parliamentary Secretary of State at the Federal Ministry for Economic Affairs and Energy (BMWi), Christian Hirte, welcomed the delegation of 19 Japanese visitors on November 6. That evening, experts briefed the guests ahead of the trip and had dinner with their hosts. At the reception, Hirte, a Commissioner for Eastern German Affairs, praised the commitment of both the Germans and Japanese at the reception.
The tour officially got underway the next day with a visit to the German parliament, the Bundestag. A German parliamentary representative, Gabriele Katzmarek, spoke with the group about the challenges facing industrial healthcare economies, transferring the latest scientific findings into medical care, and the significance of international cooperation for biotechnology in Germany.
The talk was followed by a networking luncheon at the Japanese Embassy, where Japan's ambassador to Germany, representatives of the BMWi, and the Japan Bioindustry Association officially welcomed the visitors. Guests from Germany's healthcare industry, industrial associations, and biotechnology clusters took the opportunity to exchange ideas with their Japanese counterparts.
Additional highlights of the three-and-a-half day tour were visits to biotechnology clusters such as the Biotech Park at Berlin-Buch, the Weinberg Campus Technology Park in Halle, and Bio City Leipzig and Dresden, both in the federal state of Saxony. Cooperation in innovation, research, and development, production contracting, and the export of immaterial assets (licensing) were among the primary topics the visitors and their hosts discussed. The tour closed with a trip to Hamburg to attend "BIO-Europe 2019" from November 11 to November 13, where HEALTH MADE IN GERMANY had its own stand.
Japan and Germany began discussing partnerships in medical biotechnology at BIO-Europe in Berlin in November 2017. Since then, the partnership has deepened. HEALTH MADE IN GERMANY was present at the shared stand at Bio Japan in 2018 and 2019 in Yokohama. The initiative will also be there in October next year as well.
HEATLH MADE IN GERMANY distributes profiles of the sectors of the German healthcare industry, including medical biotechnology, both online (see below) and at trade shows. Designed to present key facts about the industry, the booklet summarizes major trends and presents market figures.
- German-Japanese Dialogue kick-off 2017. The Japanese Delegation at the Federal Ministry for Economic Affairs and Energy© Exportinitiative Gesundheitswirtschaft
- Get together with Under-Secretary of State Christian Hirte and Dr. Robert Hermann, CEO at GTAI© Exportinitiative Gesundheitswirtschaft
- Christian Hirte exchanges ideas with Japanese visitors© Exportinitiative Gesundheitswirtschaft
- Visit of the German Bundestag© Exportinitiative Gesundheitswirtschaft
- MoP Gabriele Katzmarek© Exportinitiative Gesundheitswirtschaft
- MoP Gabriele Katzmarek and the Japanese delegation© Exportinitiative Gesundheitswirtschaft
- HEALTH MADE IN GERMANY @ BIO Europe 2019© Exportinitiative Gesundheitswirtschaft